Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.7474
H.R.7474: Pharmaceutical Research Transparency Act of 2022
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced April 7, 2022
- Latest Major Action April 8, 2022
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
15 (All Democrats)
Bill Version
- Introduced in House - April 7, 2022
Bill Summary
Pharmaceutical Research Transparency Act of 2022 This bill requires the disclosure of costs associated with clinical trials and pharmaceutical research and development. Specifically, the National Institutes of Health must create a publicly available repository of cost data from certain clinical trials that test the efficacy of drugs, biological products, and devices in human subjects. For each applicable trial, the registry must, among other...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| April 8, 2022 |
Referred to the Subcommittee on Health.
|
| April 7, 2022 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
| April 7, 2022 |
Introduced in the House by Carolyn B. Maloney (D-N.Y.) |